Document Detail

Adverse outcome of using tilmicosin in a lamb with multiple ventricular septal defects.
MedLine Citation:
PMID:  19337615     Owner:  NLM     Status:  MEDLINE    
A 15-day-old, 6.08 kg, lamb was injected subcutaneously with tilmicosin 15 mg/kg body weight. Approximately 15 min later, the lamb died. During necropsy, the heart was found to have multiple ventricular septal defects. Death was attributed to sudden heart failure due to the cardiac effects of tilmicosin in a heart having congenital defects.
Georgios Christodoulopoulos
Related Documents :
18192815 - Left ventricular pseudoaneurysm: an atypical case associated with a small ventricular s...
9033325 - Outcomes after delayed sternal closure in pediatric heart operations: a 10-year experie...
14667655 - Atresia of coronary sinus ostium with retrograde drainage via persistent left superior ...
8775985 - Visual understanding of cardiac development: the neural crest's contribution.
10220645 - Prediction of human transplantation arteriopathy and coronary events with lung/heart co...
21947995 - Tako-tsubo cardiomyopathy precipitated by pheochromocytoma crisis.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Canadian veterinary journal. La revue vétérinaire canadienne     Volume:  50     ISSN:  0008-5286     ISO Abbreviation:  Can. Vet. J.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2009-04-01     Completed Date:  2009-06-30     Revised Date:  2013-06-02    
Medline Journal Info:
Nlm Unique ID:  0004653     Medline TA:  Can Vet J     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  61-3     Citation Subset:  IM    
Clinic of Medicine, School of Veterinary Medicine, University of Thessaly, Karditsa, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Animals, Newborn
Death, Sudden, Cardiac / etiology,  veterinary*
Fatal Outcome
Heart Septal Defects, Ventricular / physiopathology,  veterinary*
Sheep Diseases / physiopathology*
Tylosin / adverse effects,  analogs & derivatives*
Reg. No./Substance:
1401-69-0/Tylosin; XL4103X2E3/tilmicosin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Factors associated with the early detection of foot-and-mouth disease during the 2001 epidemic in th...
Next Document:  Cecal rupture in foals--7 cases (1996-2006).